Portal de Periódicos da CAPES

Successful pregnancy outcome under prolonged ustekinumab treatment in a patient with Crohn's disease and paradoxical psoriasis

2015; Wiley; Volume: 30; Issue: 12 Linguagem: Inglês

10.1111/jdv.13499

1468-3083

Evgenia Galli‐Novak, Sophie-Charlotte Mook, Jürgen Büning, Enno Schmidt, Detlef Zillikens, Diamant Thaçi, Ralf J. Ludwig,

Pregnancy and Medication Impact

Journal of the European Academy of Dermatology and VenereologyVolume 30, Issue 12 p. e191-e192 Letter to the Editor Successful pregnancy outcome under prolonged ustekinumab treatment in a patient with Crohn's disease and paradoxical psoriasis E. Galli-Novak, E. Galli-Novak Department of Dermatology, University of Lübeck, Lübeck, GermanyEqual contributors.Search for more papers by this authorS.-C. Mook, S.-C. Mook Department of Dermatology, University of Lübeck, Lübeck, Germany Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, GermanyEqual contributors.Search for more papers by this authorJ. Büning, J. Büning Gastroenterology, Medical Department I, University Hospital of Schleswig-Holstein, Lübeck, GermanySearch for more papers by this authorE. Schmidt, E. Schmidt Department of Dermatology, University of Lübeck, Lübeck, Germany Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, GermanySearch for more papers by this authorD. Zillikens, D. Zillikens Department of Dermatology, University of Lübeck, Lübeck, GermanySearch for more papers by this authorD. Thaci, D. Thaci Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, GermanySearch for more papers by this authorR.J. Ludwig, Corresponding Author R.J. Ludwig [email protected] Department of Dermatology, University of Lübeck, Lübeck, Germany Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, GermanyCorrespondence: R.J. Ludwig. E-mail: [email protected]Search for more papers by this author E. Galli-Novak, E. Galli-Novak Department of Dermatology, University of Lübeck, Lübeck, GermanyEqual contributors.Search for more papers by this authorS.-C. Mook, S.-C. Mook Department of Dermatology, University of Lübeck, Lübeck, Germany Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, GermanyEqual contributors.Search for more papers by this authorJ. Büning, J. Büning Gastroenterology, Medical Department I, University Hospital of Schleswig-Holstein, Lübeck, GermanySearch for more papers by this authorE. Schmidt, E. Schmidt Department of Dermatology, University of Lübeck, Lübeck, Germany Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, GermanySearch for more papers by this authorD. Zillikens, D. Zillikens Department of Dermatology, University of Lübeck, Lübeck, GermanySearch for more papers by this authorD. Thaci, D. Thaci Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, GermanySearch for more papers by this authorR.J. Ludwig, Corresponding Author R.J. Ludwig [email protected] Department of Dermatology, University of Lübeck, Lübeck, Germany Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, GermanyCorrespondence: R.J. Ludwig. E-mail: [email protected]Search for more papers by this author First published: 11 November 2015 https://doi.org/10.1111/jdv.13499Citations: 39 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Langley RG, Elewski BE, Lebwohl M et al. Secukinumab in plaque psoriasis–results of two phase 3 trials. N Engl J Med 2014; 371: 326–338. 10.1056/NEJMoa1314258 CASPubMedWeb of Science®Google Scholar 2Menter A, Thaçi D, Papp KA et al. Five-year analysis from the ESPRIT 10-year postmarketing surveillance registry of adalimumab treatment for moderate to severe psoriasis. J Am Acad Dermatol 2015; 73: 410.e6–419.e6. 10.1016/j.jaad.2015.06.038 Web of Science®Google Scholar 3Ludwig RJ, Herzog C, Rostock A et al. Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 2007; 156: 271–276. 10.1111/j.1365-2133.2006.07562.x CASPubMedWeb of Science®Google Scholar 4Yang YW, Chen CS, Chen YH, Lin HC. Psoriasis and pregnancy outcomes: a nationwide population-based study. J Am Acad Dermatol 2011; 64: 71–77. 10.1016/j.jaad.2010.02.005 PubMedWeb of Science®Google Scholar 5Martin PL, Sachs C, Imai N et al. Development in the cynomolgus macaque following administration of ustekinumab, a human anti-IL-12/23p40 monoclonal antibody, during pregnancy and lactation. Birth Defects Res B Dev Reprod Toxicol 2010; 89: 351–363. 10.1002/bdrb.20250 CASPubMedWeb of Science®Google Scholar 6Andrulonis R, Ferris LK. Treatment of severe psoriasis with ustekinumab during pregnancy. J Drugs Dermatol 2012; 11: 1240. PubMedWeb of Science®Google Scholar 7Fotiadou C, Lazaridou E, Sotiriou E, Ioannides D. Spontaneous abortion during ustekinumab therapy. J Dermatol Case Rep. 2012; 6: 105–107. 10.3315/jdcr.2012.1116 PubMedGoogle Scholar 8Alsenaid A, Prinz JC. Inadvertent pregnancy during ustekinumab therapy in a patient with plaque psoriasis and impetigo herpetiformis.[letter]. J Eur Acad Dermatol Venereol 2014; doi: 10.1111/jdv.12872. [Epub ahead of print]. 10.1111/jdv.12872 PubMedWeb of Science®Google Scholar 9Rocha K, Piccinin MC, Kalache LF, Reichert-Faria A, Silva de Castro CC. Pregnancy during Ustekinumab Treatment for Severe Psoriasis. Dermatology 2015; 231: 103–104. 10.1159/000380880 PubMedWeb of Science®Google Scholar 10Sheeran C, Nicolopoulos J. Pregnancy outcomes of two patients exposed to ustekinumab in the first trimester.[letter]. Australas J Dermatol 2014; 55: 235–236. 10.1111/ajd.12214 CASPubMedWeb of Science®Google Scholar Citing Literature Volume30, Issue12December 2016Pages e191-e192 ReferencesRelatedInformation